IC
DERM icon

Ikarian Capital’s Journey Medical DERM Stock Holding History

Ikarian Capital’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.78M Hold
251,436
– – 0.19% 91
2026
Q1 		$1.18M Hold
251,436
– – 0.1% 109
2025
Q4 		$1.94M Buy
+251,436
New +$1.97M 0.15% 104

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Ikarian Capital's DERM Position: Q2 2026 in Review

Ikarian Capital held its Journey Medical (DERM) position steady in Q2 2026 at 251,436 shares worth $1.78M. The position accounts for 0.19% of the portfolio, ranked #91.

Ikarian Capital first reported a position in DERM in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.94M in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Ikarian Capital held 251,436 shares of Journey Medical worth $1.78M as of Q2 2026.
  • Ikarian Capital left its Journey Medical share count unchanged in Q2 2026.
  • Journey Medical made up 0.19% of Ikarian Capital's portfolio in Q2 2026, its #91 holding.
  • Ikarian Capital first reported a position in Journey Medical in Q4 2025 and has held it in 3 quarters since.
  • Ikarian Capital's Journey Medical position peaked at $1.94M in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.